
Bulletin of the Chemical Society of Japan p. 3965 - 3966 (1986)
Update date:2022-07-31
Topics:
Takenaka, Shunsuke
Ikemoto, Tetsuya
Kusabayashi, Shigekazu
The homologous series of N-<4-(4-n-alkoxybenzoyloxy)benzylidene>-4-(2-methylbutoxy)aniline (1), and N-<4-<4-(2-methylbutoxy)benzoyloxy>benzylidene>-4-n-alkoxyaniline (2), and N-<4-(4-n-alkoxybenzoyloxy)-3-hydroxybenzylidene>-4-(2-methylbutoxy)aniline (3) where the 2-methylbutoxyl group has an S-configuration, have been prepared.Series 1 and 2 form a chiral smectic C (S*C) phase in addition to a cholesteric (Ch) and a chiral smectic G (S*G) phases, and series 3 form (S*C) and Ch phases.
View MoreChengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd.
Contact:+86-21-51320130-801, 816
Address:Room 601, No. 1011, Halei Road, Zhangjiang High-Tech Park, Pudong, Shanghai
Jinan Kaypharm Chemical Co.,Ltd
Contact:86-0531-86986780
Address:Room101,No189-2,Huayuan Road,Jinan City,Shandong Province
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
Contact:+86-517-86283327
Address:9 North Hantai Road, Huaian, China
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Doi:10.1002/ps.588
(2002)Doi:10.1039/c9sc04752b
(2019)Doi:10.1021/jo980941i
(1998)Doi:10.1021/acs.joc.9b03054
(2020)Doi:10.1016/S0040-4039(00)75550-X
(1968)Doi:10.1002/cmdc.201100283
(2011)